ENTITY
Opthea Ltd

Opthea Ltd (OPT AU)

23
Analysis
Health CareAustralia
Opthea Limited is a biologics drug developer for ophthalmic diseases. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
more
03 Apr 2025 16:25

ASX Short Interest Weekly (Mar 28th): Commonwealth Bank Of Australia, James Hardie Industries

We analyzed ASX short interest report for the past week and highlight short interest changes in Commonwealth Bank Of Australia, James Hardie...

Logo
242 Views
Share
21 Mar 2025 11:00

ASX Short Interest Weekly (Mar 14th): Lottery, Telstra, Sigma Pharmaceuticals

We analyzed ASX short interest report for the past week and highlight short interest changes in Lottery, Telstra, Sigma Pharmaceuticals.

Logo
422 Views
Share
20 Sep 2024 09:08

S&P/​​​​ASX Index Rebalance (Sep 2024): Two Big Surprises; Positioning Is Mixed

The index rebalances at the close today. Stocks have moved a lot over the last couple of weeks since announcements and some positioning will be...

Logo
937 Views
Share
22 Aug 2024 07:09

S&P/​​​​​​​​​ASX Index Rebalance Preview: Review Period Nearly Done; Big Impact Changes

There could be 30 changes for the ASX indices in September with a lot to trade for passive trackers. The adds have outperformed the deletes and...

Logo
561 Views
Share
x